Virtual Booth

NeuroBreath™ is an innovative, portable breath-based device designed to enable early detection of Mild Cognitive Impairment (MCI) through the analysis of volatile organic compounds (VOCs) in exhaled breath. By targeting key biomarkers such as acetone, isoprene, and aldehydes, linked to neurodegenerative changes, the device offers a non-invasive, rapid, and user-friendly screening tool suitable for clinical and community settings. NeuroBreath™ provides an instant cognitive risk score, empowering timely intervention and monitoring. This low-cost, scalable solution bridges the gap between current diagnostic limitations and the need for accessible early detection, supporting efforts to delay progression to dementia through proactive brain health screening.